Name

NanoDiagnostika

Legal name

Obshchestvo s ogranichennoy otvetstvennostyu «NanoDiagnostika» (ООО «НаноДиагностика»)

Website

https://moldi.ru

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Laboratory Services

NAICS

Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Genetic & Prenatal Testing Laboratories (HLAFAMAH), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology) (HLAMADAE), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

Keywords

• Molecular diagnostics
• PCR testing services
• Prenatal genetic testing
• Veterinary diagnostics
• Infectious disease testing

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory diagnostic services (PCR and ELISA): Service laboratory providing diagnostic services using PCR and ELISA technologies to medical institutions and private individuals. Services include infectious disease testing, prenatal sex determination, and Rh factor testing.
2. PCR test systems for sale (veterinary, medical, research): Sale of proprietary PCR test systems to veterinary clinics, medical laboratories, and research institutions. Products sold in packs of 100 tests. Loyalty programs for large-volume buyers include special forms of delivery, wholesale prices, and individual assembly.
3. Non-invasive prenatal tests (НИПТ): NIPT panels (basic, standard, extended) for screening chromosomal abnormalities in fetus from maternal blood, priced at 20,000–33,000 RUB per test plus blood draw fee.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

NanoDiagnostika is a Moscow-based medical and veterinary diagnostic laboratory that provides infectious disease testing (PCR and ELISA), non-invasive prenatal testing (NIPT), early fetal sex determination from maternal blood, and Rh factor testing. The company also develops, manufactures (under ISO 13485), and sells proprietary PCR test systems to veterinary clinics, medical laboratories, and research institutions for detection of pathogens and genetic targets.

Differentiator

Problem solved

Functional benefit

Products and services

• PCR-Based Infectious Disease Diagnostics Laboratory diagnostic service using real-time PCR to detect infectious agents in patient samples, including Chlamydia trachomatis (400 RUB), HPV without typing (300 RUB), HPV with 8-type typing (500 RUB), and other agents (300 RUB). Offered to individual consumers and partner medical institutions in Russia.
• Prenatal Fetal Sex Determination from Maternal Blood Non-invasive DNA-based fetal sex determination from maternal blood using real-time PCR targeting Y-chromosome DAZ gene marker, available from 7 weeks gestation. Standard package priced at 6,000 RUB including blood draw with 95% accuracy at 7-9 weeks and 99%+ from 12 weeks; 'Super Accuracy' package at 8,500 RUB with up to 99.9% accuracy. Results delivered next business day.
• Non-Invasive Prenatal Testing (NIPT) Non-invasive prenatal testing panels for chromosomal abnormality screening from maternal blood: Basic panel (20,000 RUB + 500 RUB blood draw, screens trisomies 21/18/13, 8 business days turnaround); Standard panel (23,000 RUB, adds sex chromosome aneuploidies); Extended panel (33,000 RUB, adds microdeletion syndromes and 18 autosomal-recessive conditions, with free confirmatory CMA if high risk). Extended panel interpreted by Genom Laboratory.
• Fetal Rh Factor Determination Non-invasive determination of fetal Rh factor from maternal blood to assess Rh incompatibility risk for Rh-negative pregnant women. Free for Rh-negative women as part of clinical trial program; otherwise offered at standard laboratory pricing.
• ELISA Antibody Testing Services

Quantifiable outcome

• Fetal sex determination accuracy: 95% at 7–9 weeks, 97% at 9–11 weeks, 99%+ from 12 weeks (99.92% accuracy reported for 2018 service year)
• +4 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Four partnerships are on record, tiered core and minor.

• NIts 'Kurchatovskiy institut' (Kurchatov Institute)coreStrategic or Co-development Partner · 7 June 2026Joint research collaboration with the Kurchatov Institute's Resource Center for Cellular and Gene Technologies. The company was founded on the basis of the Institute of Molecular Genetics of the Russian Academy of Sciences and continues close research ties with the Kurchatov Institute. CEO Demkin V.V. heads the Resource Center of Cell and Gene Technologies at the Kurchatov Institute. Joint conference presentations on prenatal diagnostics.
• RNIMU im. N.I. Pirogova (Pirogov Russian National Research Medical University)minorStrategic or Co-development Partner · 7 June 2026Joint research collaboration presented at the XXXIIII International Conference on New Technologies in Medicine, Biology, Pharmacology and Ecology, alongside the Kurchatov Institute and NanoDiagnostika.
• Institut molekulyarnoy genetiki RAN (Institute of Molecular Genetics, Russian Academy of Sciences)coreStrategic or Co-development Partner · 1 January 2021Founding institution of NanoDiagnostika. The company was established in 2008 on the basis of this institute. Ongoing joint research including publication on feline hemotropic mycoplasmas in Preventive Veterinary Medicine journal.
• Medical centers in Russian cities (Korolev, Nalchik, Nizhny Novgorod, Pyatigorsk, Tver, Cheboksary)minorChannel Partner/ Reseller/ DistributorNetwork of partner medical organizations collecting blood samples and forwarding them to NanoDiagnostika's Moscow laboratory for analysis. Includes women's consultations, polyclinics, fertility clinics, and medical centers. Partners include: Women's consultation at GB No.2 (Korolev), Polyclinic No.1 of MSU No.170 (Korolev), Klinika 'Andromeda' (Nalchik), 'Akademiya VIP' (Nizhny Novgorod), 'Papa, mama i malysh' fertility clinic (Nizhny Novgorod), 'AGADA' clinic (Pyatigorsk), 'Genetis' reproductive clinic (Tver), 'Novaya laboratoriya' MC (Tver), 'Otkrytie' MC (Cheboksary).

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Hologic: Global molecular diagnostics and IVD manufacturer whose Panther system and Aptima assays serve PCR-based infectious disease and women's health diagnostics markets. Comparable at the IVD technology level with NanoDiagnostika's PCR test systems.
• KDL Laboratory: Large Russian clinical laboratory network performing PCR, ELISA, genetic, and general clinical diagnostics. Comparable in service offering but at substantially larger scale across multiple Russian cities.
• CMD (Center for Molecular Diagnostics): Russian PCR-focused diagnostics network specializing in molecular infectious disease testing. Direct overlap with NanoDiagnostika's PCR infectious disease diagnostic services, with broader geographic coverage.
• Helix Laboratory Service: Major Russian clinical diagnostics laboratory offering PCR, genetic testing, and a wide range of medical analyses. Comparable to NanoDiagnostika in core molecular diagnostics services but operates at significantly larger scale with broader test menu.
• LabQuest: Russian medical laboratory network with PCR, ELISA, and molecular diagnostics offerings. Comparable service mix and Russian market focus, but at larger operational scale.
• Gemotest: Russian clinical diagnostics chain offering comprehensive medical testing including PCR-based infectious disease diagnostics and genetic testing. Competes with NanoDiagnostika in PCR infectious disease services with broader scale.
• INVITRO: Russia's largest private medical diagnostics chain, offering a broad menu of laboratory tests including PCR, ELISA, and NIPT across hundreds of locations. Direct competitor to NanoDiagnostika in clinical diagnostics with significantly greater scale and brand recognition, though less specialized in proprietary PCR test-system production.

Direct peers

• Natera: US-based molecular diagnostics company specializing in non-invasive prenatal testing (NIPT) and cell-free DNA applications. Directly comparable technology and product overlap with NanoDiagnostika's NIPT and fetal sex determination services, though at significantly larger scale and with global market reach.
• Genom Laboratory: Russian molecular genetics laboratory with which NanoDiagnostika has a referral partnership for NIPT Extended Panel interpretation and confirmatory chromosomal microarray analysis. Comparable as a direct NIPT and molecular diagnostics service provider.

Regional players

• Syntol (Russia): Russian developer and manufacturer of PCR test systems and reagents for medical and veterinary diagnostics. Directly comparable to NanoDiagnostika's proprietary PCR test-system production business, with overlap in veterinary and medical PCR reagent markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NanoDiagnostika